News and Trends 3 Mar 2023
Lilly to develop Confo pain drug
Confo Therapeutics, which works on the discovery of medicines targeting G-protein coupled receptors (GPCRs), has announced a worldwide licensing agreement…
Confo Therapeutics
- Latest Posts
News and Trends 7 May 2019
Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets
Confo Therapeutics has raised €30M in a Series A round that will take its unique technology to find drugs for…
News and Trends 19 Dec 2017
Belgian Biotech and Roche Take on Neurological and Developmental Disorders
Confo Therapeutics has joined forces with Roche to develop new small molecule agonists of a G-protein coupled receptor to treat…
News and Trends 26 Sep 2017
Belgian Biotech Teams Up With Lundbeck to Collaborate on Drug Discovery
Confo and Lundbeck have joined forces to push through drug discovery against a tough-to-target protein using Confo's special technology. Confo Therapeutics develops small…
ADVERTISEMENT
In Depth 6 Jun 2017
A Painful Case: How Biotech is trying to Break Through in Analgesia
Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great, and which biotechs are gunning…
News and Trends 1 Feb 2017
Young Belgian Biotech will tackle Fibrosis with a New Grant
Confo Therapeutics has received a €1.6M grant to support the discovery of drugs against fibrosis, one of the most deadly…
News and Trends 23 Nov 2016
These Biotech Veterans have Launched a Startup to ‘Drug the Undruggable’
GPCRs have spelled “dead end” for many a biotech and academic endeavor. I sat down with Confo Therapeutics to hear…
